CLASS II Drug recall · Reported 20 Feb 2013 · FDA Enforcement Report

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg recalled

Upsher Smith Laboratories is recalling Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, distributed in Florida, New Jersey. The recall was initiated on 20 Nov 2012 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #308198, Expiration Date is 03/2014
Quantity recalled60 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-160-2013
FDA event ID
63908
Recalling firm
Upsher Smith Laboratories, Maple Grove, MN
Classification
Class II
Status
Terminated
Recall initiated
20 Nov 2012
FDA classified
8 Feb 2013
Reported
20 Feb 2013
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Potency & Assay

Timeline

20 Nov 2012Recall initiated by company
8 Feb 2013Classified by FDA+80 days
20 Feb 2013Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Test Requirements

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Propranolol Hydrochloride Extended-release Capsules, USP, 80 mg, 100 Capsules, Rx only, Manufactured for Upsher Smith Laboratories, Inc Minneapolis MN 55447 --- NDC 0245-0085-11, UPC 3 0245-0085-11 9

Where it was distributed

FL, NJ.

FloridaNew Jersey

Questions about this recall

Why was it recalled?

Failed Dissolution Test Requirements

Which lots are affected?

Lot #308198, Expiration Date is 03/2014

Where was it sold?

FL, NJ.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Upsher Smith Laboratories

All 6

Other Propranolol recalls

All 12